Prognostic and Immunological Significance of CXCR2 in Ovarian Cancer: A Promising Target for Survival Outcome and Immunotherapeutic Response Assessment

Table 1

The first 20 upregulated CXCR2-relevant genes ranked by |log2fold change|.

Genes	log2fold change	Average expression		value	FDR
CYBB	1.626883	4.866193	13.2859	2.82-33	3.13-30	64.80304
CSF1R	1.580807	5.08034	13.53358	2.96-34	4.76-31	67.02763
ALOX5AP	1.572744	5.250381	11.77966	1.82-27	4.82-25	51.62072
LYZ	1.530011	6.245003	9.038626	8.60-18	6.04-16	29.71133
SLCO2B1	1.489949	3.454025	14.24883	4.06-37	2.39-33	73.52581
MPEG1	1.475656	3.816864	13.79154	2.78-35	5.46-32	69.35911
VSIG4	1.457472	5.213007	11.87514	7.96-28	2.39-25	52.43645
FPR3	1.439832	4.19429	11.74373	2.49-27	6.48-25	51.31448
LAPTM5	1.439653	7.33844	12.34081	1.35-29	5.82-27	56.45608
FCGR3A	1.435916	5.415789	11.59154	9.24-27	2.07-24	50.02226
CX3CR1	1.428444	3.051211	11.38818	5.27-26	1.01-23	48.30796
C3AR1	1.406321	4.279677	12.81774	1.93-31	1.27-28	60.6387
ITGB2	1.391398	4.898533	11.96583	3.62-28	1.23-25	53.21399
CD163	1.390154	4.016596	11.86577	8.64-28	2.55-25	52.35628
GPR34	1.38616	3.462056	13.89462	1.08-35	2.91-32	70.29467
FPR1	1.372222	2.86155	12.72349	4.49-31	2.57-28	59.80717
F13A1	1.352817	3.950676	10.18952	1.10-21	1.22-19	38.51989
SIGLEC1	1.343363	3.306899	11.83175	1.16-27	3.17-25	52.06539
FGL2	1.311918	3.734005	11.99986	2.69-28	9.33-26	53.50643
MNDA	1.30756	3.392344	13.16289	8.62-33	8.98-30	63.70358